Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehto, S.
Right arrow Articles by Laakso, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehto, S.
Right arrow Articles by Laakso, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes

(Stroke. 1998;29:635-639.)
© 1998 American Heart Association, Inc.


Original Contributions

Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus

Seppo Lehto, MD; Leo Niskanen, MD; Tapani Rönnemaa, MD; Markku Laakso, MD

From the Department of Medicine, University of Kuopio (Finland) (S.L., L.N., M.L.), the Department of Medicine, University of Turku (T.R.), and The Social Insurance Institution (T.R.), Turku, Finland.

Correspondence to Markku Laakso, MD, Professor and Chair, Department of Medicine, University of Kuopio, SF-70210 Kuopio, Finland. E-mail markku.laakso{at}uku.fi

Background and Purpose—Patients with non–insulin-dependent diabetes mellitus (NIDDM) are at increased risk for stroke. Hyperuricemia is a common finding in NIDDM, but its significance as an independent risk factor for cardiovascular disease has remained uncertain. Therefore, we investigated serum urate as a predictor of stroke in NIDDM patients free of clinical nephropathy (ie, with a serum creatinine level of <=120 µmol/L).

Methods—In this population-based study, cardiovascular risk factors were determined in 1017 patients (551 men and 466 women) with NIDDM, aged 45 to 64 years at baseline. The patients were followed up for 7 years with respect to stroke events.

Results—During the follow-up period, 31 NIDDM patients (12 men [2.2%] and 19 women [4.1%]) died from stroke and 114 NIDDM patients (55 men [10.0%] and 59 women [12.7%]) had a fatal or nonfatal stroke. The incidence of stroke increased significantly by quartiles of serum uric acid levels (P<.001). High uric acid level (above the median value of >295 µmol/L) was significantly associated with the risk of fatal and nonfatal stroke by Cox regression analysis (hazard ratio, 1.93 [1.30 to 2.86]; P=.001). This association remained statistically significant even after adjustment for all cardiovascular risk factors (hazard ratio, 1.91 [1.24 to 2.94[; P=.003).

Conclusions—Our results indicate that hyperuricemia is a strong predictor of stroke events in middle-aged patients with NIDDM independently of other cardiovascular risk factors.


Key Words: diabetes mellitus • mortality • uric acid • stroke onset




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. D. Cohen, P. L. Kimmel, R. Neff, L. Agodoa, and K. C. Abbott
Association of Incident Gout and Mortality in Dialysis Patients
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2204 - 2210.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
W T. Cade
Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Physical Therapy, November 1, 2008; 88(11): 1322 - 1335.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. I. Feig, D.-H. Kang, and R. J. Johnson
Uric Acid and Cardiovascular Risk
N. Engl. J. Med., October 23, 2008; 359(17): 1811 - 1821.
[Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
D. Sander, K. Sander, and H. Poppert
Review: Stroke in type 2 diabetes
The British Journal of Diabetes & Vascular Disease, September 1, 2008; 8(5): 222 - 229.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Meisinger, W. Koenig, J. Baumert, and A. Doring
Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General Population: The MONICA/KORA Cohort Study
Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1186 - 1192.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. J. Schretlen, A. B. Inscore, T. D. Vannorsdall, M. Kraut, G. D. Pearlson, B. Gordon, and H. A. Jinnah
Serum uric acid and brain ischemia in normal elderly adults
Neurology, October 2, 2007; 69(14): 1418 - 1423.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
J. F. Baker, H. R. Schumacher, and E. Krishnan
Serum Uric Acid Level and Risk for Peripheral Arterial Disease: Analysis of Data From the Multiple Risk Factor Intervention Trial
Angiology, September 1, 2007; 58(4): 450 - 457.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, H. J. Milionis, K. M. J. Douglas, P. Nightingale, M. D. Kita, R. Klocke, M. S. Elisaf, and G. D. Kitas
Association of serum uric acid with cardiovascular disease in rheumatoid arthritis
Rheumatology, September 1, 2007; 46(9): 1466 - 1470.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Alderman
Podagra, Uric Acid, and Cardiovascular Disease
Circulation, August 21, 2007; 116(8): 880 - 883.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
V. G. Athyros, D. P. Mikhailidis, E. N. Liberopoulos, A. I. Kakafika, A. Karagiannis, A. A. Papageorgiou, K. Tziomalos, E. S. Ganotakis, and M. Elisaf
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 118 - 127.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Papazafiropoulou, N. Tentolouris, I. Moyssakis, D. Perrea, and N. Katsilambros
The Potential Effect of Some Newer Risk Factors for Atherosclerosis on Aortic Distensibility in Subjects With and Without Type 2 Diabetes
Diabetes Care, August 1, 2006; 29(8): 1926 - 1928.
[Full Text] [PDF]


Home page
StrokeHome page
M. J. Bos, P. J. Koudstaal, A. Hofman, J. C.M. Witteman, and M. M.B. Breteler
Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study
Stroke, June 1, 2006; 37(6): 1503 - 1507.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Zoccali, R. Maio, F. Mallamaci, G. Sesti, and F. Perticone
Uric Acid and Endothelial Dysfunction in Essential Hypertension
J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1466 - 1471.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
M. Kikura, T. Takada, and S. Sato
Preexisting Morbidity as an Independent Risk Factor for Perioperative Acute Thromboembolism Syndrome
Arch Surg, December 1, 2005; 140(12): 1210 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
E Suresh
Diagnosis and management of gout: a rational approach
Postgrad. Med. J., September 1, 2005; 81(959): 572 - 579.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. J. Milionis, E. Rizos, J. Goudevenos, K. Seferiadis, D. P. Mikhailidis, and M. S. Elisaf
Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects
Stroke, July 1, 2005; 36(7): 1372 - 1376.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Ishizaka, Y. Ishizaka, E.-I. Toda, R. Nagai, and M. Yamakado
Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1038 - 1044.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Viazzi, D. Parodi, G. Leoncini, A. Parodi, V. Falqui, E. Ratto, S. Vettoretti, G. P. Bezante, M. Del Sette, G. Deferrari, et al.
Serum Uric Acid and Target Organ Damage in Primary Hypertension
Hypertension, May 1, 2005; 45(5): 991 - 996.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. K. Niskanen, D. E. Laaksonen, K. Nyyssonen, G. Alfthan, H.-M. Lakka, T. A. Lakka, and J. T. Salonen
Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men: A Prospective Cohort Study
Arch Intern Med, July 26, 2004; 164(14): 1546 - 1551.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S.-P. Hsu, M.-F. Pai, Y.-S. Peng, C.-K. Chiang, T.-I Ho, and K.-Y. Hung
Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients
Nephrol. Dial. Transplant., February 1, 2004; 19(2): 457 - 462.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
W S Waring, S H Adwani, O Breukels, D J Webb, and S R J Maxwell
Hyperuricaemia does not impair cardiovascular function in healthy adults
Heart, February 1, 2004; 90(2): 155 - 159.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Chamorro, A. M. Planas, C. J. Weir, S. W. Muir, M. R. Walters, and K. R. Lees
Yin and Yang of Uric Acid in Patients With Stroke * Response
Stroke, January 1, 2004; 35 (1): e11 - e12.
[Full Text] [PDF]


Home page
StrokeHome page
J. Kanellis and R. J. Johnson
Editorial Comment--Elevated Uric Acid and Ischemic Stroke: Accumulating Evidence That It Is Injurious and Not Neuroprotective
Stroke, August 1, 2003; 34(8): 1956 - 1957.
[Full Text] [PDF]


Home page
HypertensionHome page
R. J. Johnson, D.-H. Kang, D. Feig, S. Kivlighn, J. Kanellis, S. Watanabe, K. R. Tuttle, B. Rodriguez-Iturbe, J. Herrera-Acosta, and M. Mazzali
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Hypertension, June 1, 2003; 41(6): 1183 - 1190.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
W.S. WARING
Uric acid: an important antioxidant in acute ischaemic stroke
QJM, October 1, 2002; 95(10): 691 - 693.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. Seghieri, D. Moruzzo, S. Fascetti, C. Bambini, R. Anichini, A. De Bellis, L. Alviggi, and F. Franconi
Increase in Serum Uric Acid Is Selectively Associated With Stroke in Type 2 Diabetes
Diabetes Care, June 1, 2002; 25(6): 1095 - 1095.
[Full Text] [PDF]


Home page
Eur Heart JHome page
K.Y.K. Wong, R.S. Macwalter, H.W. Fraser, I. Crombie, S.A. Ogston, and A.D. Struthers
Urate predicts subsequent cardiac death in stroke survivors
Eur. Heart J., May 2, 2002; 23(10): 788 - 793.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Chamorro, V. Obach, A. Cervera, M. Revilla, R. Deulofeu, and J. H. Aponte
Prognostic Significance of Uric Acid Serum Concentration in Patients With Acute Ischemic Stroke
Stroke, April 1, 2002; 33(4): 1048 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
H.U. HINK and T. FUKAI
Extracellular Superoxide Dismutase, Uric Acid, and Atherosclerosis
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 483 - 490.
[Abstract] [PDF]


Home page
HypertensionHome page
J.-G. Wang, J. A. Staessen, R. H. Fagard, W. H. Birkenhager, L. Gong, and L. Liu
Prognostic Significance of Serum Creatinine and Uric Acid in Older Chinese Patients With Isolated Systolic Hypertension
Hypertension, April 1, 2001; 37(4): 1069 - 1074.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. I. McFarlane, M. Banerji, and J. R. Sowers
Insulin Resistance and Cardiovascular Disease
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 713 - 718.
[Full Text]


Home page
HypertensionHome page
P. Verdecchia, G. Schillaci, G. Reboldi, F. Santeusanio, C. Porcellati, and P. Brunetti
Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension : The PIUMA Study
Hypertension, December 1, 2000; 36(6): 1072 - 1078.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
W.S. Waring, D.J. Webb, and S.R.J. Maxwell
Uric acid as a risk factor for cardiovascular disease
QJM, November 1, 2000; 93(11): 707 - 713.
[Full Text] [PDF]


Home page
IOVSHome page
C. K. M. Choy, I. F. F. Benzie, and P. Cho
Ascorbic Acid Concentration and Total Antioxidant Activity of Human Tear Fluid Measured Using the FRASC Assay
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3293 - 3298.
[Abstract] [Full Text]


Home page
StrokeHome page
A. Cherubini, M. C. Polidori, M. Bregnocchi, S. Pezzuto, R. Cecchetti, T. Ingegni, A. di Iorio, U. Senin, and P. Mecocci
Antioxidant Profile and Early Outcome in Stroke Patients
Stroke, October 1, 2000; 31(10): 2295 - 2300.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. J. Johnson, K. R. Tuttle, B. Culleton, and D. Levy
Much Ado About Nothing, or Much to Do About Something? The Continuing Controversy Over the Role of Uric Acid in Cardiovascular Disease
Hypertension, March 1, 2000; 35 (3): e10 - e10.
[Full Text]


Home page
Nephrol Dial TransplantHome page
J. Syrjanen, J. Mustonen, and A. Pasternack
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy
Nephrol. Dial. Transplant., January 1, 2000; 15(1): 34 - 42.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
B. F. Culleton, M. G. Larson, W. B. Kannel, and D. Levy
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Ann Intern Med, July 6, 1999; 131(1): 7 - 13.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. H. Alderman, H. Cohen, S. Madhavan, and S. Kivlighn
Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
Hypertension, July 1, 1999; 34(1): 144 - 150.
[Abstract] [Full Text] [PDF]